AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X

All Manufacturers, Suppliers, Distributors and Exporters of Morphine Sulfate with approved Health Canada of Finished Dosage Form listed on PharmaCompass.com

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES

0

Flag Switzerland
Digital Content Digital Content
URL Supplier Web Content
SOLUTION
0.5MG/ML
MORPHINE LP EPIDURAL
2021056
5X10ML
Narcotic (CDSA I)
Canada
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Switzerland
Digital Content Digital Content
URL Supplier Web Content
SOLUTION
1MG/ML
MORPHINE LP EPIDURAL
2021048
5X5ML
Narcotic (CDSA I)
Canada
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Switzerland
Digital Content Digital Content
URL Supplier Web Content
SOLUTION
50MG/ML
MORPHINE HP 50
617288
1/5/10/50ML
Narcotic (CDSA I)
Canada
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Switzerland
Digital Content Digital Content
URL Supplier Web Content
LIQUID
10MG/ML
MORPHINE SULFATE INJ 10MG/ML USP
392588
10X1ML/25X1ML
Narcotic (CDSA I)
Canada
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Switzerland
Digital Content Digital Content
URL Supplier Web Content
LIQUID
15MG/ML
MORPHINE SULFATE INJ 15MG/ML USP
392561
10X1ML/25X1ML/1X30ML
Narcotic (CDSA I)
Canada
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Switzerland
Digital Content Digital Content
URL Supplier Web Content
TABLET (EXTENDED-RELEASE)
15MG
SANDOZ MORPHINE SR
2244790
100
Narcotic (CDSA I)
Canada
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Switzerland
Digital Content Digital Content
URL Supplier Web Content
TABLET (EXTENDED-RELEASE)
30MG
SANDOZ MORPHINE SR
2244791
100
Narcotic (CDSA I)
Canada
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Switzerland
Digital Content Digital Content
URL Supplier Web Content
TABLET (EXTENDED-RELEASE)
60MG
SANDOZ MORPHINE SR
2244792
100
Narcotic (CDSA I)
Canada
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Switzerland
Digital Content Digital Content
URL Supplier Web Content
LIQUID
2MG/ML
MORPHINE SULFATE INJECTION USP
2242484
1 ML
Narcotic (CDSA I)
Canada
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Switzerland
Digital Content Digital Content
URL Supplier Web Content
TABLET (EXTENDED-RELEASE)
100MG
SANDOZ MORPHINE SR
2478889
50
Narcotic (CDSA I)
Canada
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Switzerland
Digital Content Digital Content
URL Supplier Web Content
TABLET (EXTENDED-RELEASE)
200MG
SANDOZ MORPHINE SR
2478897
50
Narcotic (CDSA I)
Canada
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Switzerland
Digital Content Digital Content
URL Supplier Web Content
SOLUTION
10MG/ML
MORPHINE SULFATE INJECTION SDZ
2382997
5X1ML/5X5ML
Narcotic (CDSA I)
Canada
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
left grey arrow
right gray arrow
  • TABLET, EXTENDED RELEASE;ORAL - 100MG
  • TABLET, EXTENDED RELEASE;ORAL - 15MG
  • TABLET, EXTENDED RELEASE;ORAL - 200MG
  • TABLET, EXTENDED RELEASE;ORAL - 30MG
  • TABLET, EXTENDED RELEASE;ORAL - 60MG
  • INJECTABLE;INJECTION - 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • INJECTABLE;INJECTION - 5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • SOLUTION;INTRAMUSCULAR - 10MG/0.7ML (10MG/0.7ML)
  • INJECTABLE;INJECTION - 10MG/ML
  • INJECTABLE;INJECTION - 15MG/ML
  • INJECTABLE;INJECTION - 2MG/ML
  • INJECTABLE;INJECTION - 4MG/ML
  • INJECTABLE;INJECTION - 50MG/ML
  • INJECTABLE;INJECTION - 8MG/ML
  • CAPSULE, EXTENDED RELEASE;ORAL - 100MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 10MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 130MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 150MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 200MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 20MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 30MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 40MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 50MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 60MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 70MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 80MG
  • TABLET, EXTENDED RELEASE;ORAL - 100MG
  • TABLET, EXTENDED RELEASE;ORAL - 15MG
  • TABLET, EXTENDED RELEASE;ORAL - 30MG
  • TABLET, EXTENDED RELEASE;ORAL - 60MG
  • TABLET, EXTENDED RELEASE;ORAL - 15MG
  • TABLET, EXTENDED RELEASE;ORAL - 30MG
  • TABLET, EXTENDED RELEASE;ORAL - 60MG
  • SOLUTION;ORAL - 100MG/5ML
  • SOLUTION;ORAL - 10MG/5ML
  • SOLUTION;ORAL - 20MG/5ML
  • TABLET;ORAL - 15MG
  • TABLET;ORAL - 30MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 100MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • CAPSULE, EXTENDED RELEASE;ORAL - 20MG;0.8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • CAPSULE, EXTENDED RELEASE;ORAL - 30MG;1.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • CAPSULE, EXTENDED RELEASE;ORAL - 50MG;2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • CAPSULE, EXTENDED RELEASE;ORAL - 60MG;2.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • CAPSULE, EXTENDED RELEASE;ORAL - 80MG;3.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY